What is he best known for?
The fields of study he is best known for:
The scientist’s investigation covers issues in Antigen, Immunology, CTL*, Melanoma and Molecular biology.
His Antigen study integrates concerns from other disciplines, such as Cytotoxic T cell and Peptide sequence, Gene.
His Immunology research is multidisciplinary, relying on both Cancer, Cancer research and Cytolysis, Cytotoxicity.
The CTL* study combines topics in areas such as Mastocytoma, Mast cell sarcoma, Tyrosinase, Clone and Tumor antigen.
His study in Melanoma is interdisciplinary in nature, drawing from both Gene expression, MART-1 Antigen, Cellular immunity, Metastasis and Vaccination.
His Molecular biology research incorporates elements of DNA methylation, Transfection, cDNA library, Mutagenesis and Signal peptide.
His most cited work include:
- A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma (3136 citations)
- Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase (1739 citations)
- Tumor-antigens recognized by T-lymphocytes (1206 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Antigen, Immunology, Molecular biology, CTL* and Gene.
His work deals with themes such as Cytotoxic T cell, Cytolysis, Melanoma and Virology, which intersect with Antigen.
Thierry Boon has included themes like Cancer and Cancer research in his Immunology study.
His Molecular biology study incorporates themes from Gene family, Mastocytoma, Transfection, Peptide sequence and Exon.
His CTL* study also includes fields such as
- Human leukocyte antigen that connect with fields like Antigen presentation,
- Peptide which intersects with area such as Proteasome.
Thierry Boon combines subjects such as Clone and Cytotoxicity with his study of T lymphocyte.
He most often published in these fields:
- Antigen (82.74%)
- Immunology (55.07%)
- Molecular biology (52.33%)
What were the highlights of his more recent work (between 2002-2019)?
- Antigen (82.74%)
- Immunology (55.07%)
- CTL* (47.40%)
In recent papers he was focusing on the following fields of study:
Antigen, Immunology, CTL*, Melanoma and Cytotoxic T cell are his primary areas of study.
His studies in Antigen integrate themes in fields like Cancer, Gene, Molecular biology and Cancer immunotherapy.
His Gene study combines topics from a wide range of disciplines, such as Peptide, Human leukocyte antigen and Cytolysis.
His CTL* research incorporates themes from Cancer immunology, Cancer research, T-cell receptor and Virology.
As a part of the same scientific family, Thierry Boon mostly works in the field of Melanoma, focusing on Adjuvant and, on occasion, QS21.
Thierry Boon has researched Cytotoxic T cell in several fields, including Lymph node and Monoclonal.
Between 2002 and 2019, his most popular works were:
- Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase (1739 citations)
- Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy. (579 citations)
- Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy. (579 citations)
In his most recent research, the most cited papers focused on:
His primary areas of study are Immunology, Antigen, Melanoma, CTL* and Cytotoxic T cell.
His Immunology research includes themes of Cancer and Toxicity.
His Antigen research is multidisciplinary, incorporating elements of Antigen presentation and Follicular dendritic cells.
His studies deal with areas such as Pathology, Germinal center, Immune system and Immunoglobulin class switching as well as Melanoma.
His research investigates the link between CTL* and topics such as T-cell receptor that cross with problems in Immunization and Virology.
Thierry Boon works mostly in the field of CD8, limiting it down to topics relating to Ex vivo and, in certain cases, Effector, Colocalization, Galectin, T lymphocyte and Cancer research, as a part of the same area of interest.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
